Novel Antitrypanosomal and Antimalarial Structures
Journal of Medicinal Chemistry, 2005, Vol. 48, No. 25 8097
(23) Augustyns, K.; Amssoms, K.; Yamani, A.; Rajan, P. K.; Haemers,
A. Trypanothione as a Target in the Design of Antitrypanosomal
and Antileishmanial Agents. Curr. Pharm. Des. 2001, 7, 1117-
1141.
(24) Baillet, S.; Buisine, E.; Horvath, D.; Maes, L.; Bonnet, B.;
Sergheraert, C. 2-Amino Diphenylsulfides as Inhibitors of Try-
panothione Reductase: Modification of the Side Chain. Bioorg.
Med. Chem. 1996, 4, 891-899.
(25) Girault, S.; Baillet, S.; Horvath, D.; Lucas, V.; Davioud-Charvet,
E.; Tartar, A.; Sergheraert, C. New Potent Inhibitors of Try-
panothione Reductase from Trypanosoma cruzi in the 2-Ami-
nodiphenylsulfide Series. Eur. J. Med. Chem. 1997, 32, 39-52.
(26) Fernandez-Gomez, R.; Moutiez, M.; Aumercier, M.; Bethegnies,
G.; Luyckx, M.; Ouaissi, A.; Tartar, A.; Sergheraert, C. 2-Amino
Diphenyldisulfides as New Inhibitors of Trypanothione Reduc-
tase. Int. J. Antimicrob. Agents 1995, 6, 111-118.
(27) Bonnet, B.; Soullez, D.; Davioud-Charvet, E.; Landry, V.; Hor-
vath, D.; Sergheraert, C. New Spermine and Spermidine Deriva-
tives as Potent Inhibitors of Trypanosoma cruzi Trypanothione
Reductase. Bioorg. Med. Chem. 1997, 5, 1249-1256.
(28) Henderson, G. B.; Fairlamb, A. H.; Ulrich, P.; Cerami, A.
Substrate Specificity of the Flavoproetin Trypanothione Disul-
fide Reductase from Crithidia fasciculata. Biochemistry 1987,
26, 3023-3027.
(29) El-Waer, A. F.; Smith, K.; McKie, J. H.; Benson, T. J.; Fairlamb,
A. H.; Douglas, K. T. The Glutamyl Binding Site of Trypan-
othione Reductase from Crithidia fasciculata: Enzyme Kinetic
Properties of Gamma-glutamyl-modified Substrate Analogues.
Biochim. Biophys. Acta 1993, 1203, 93-98.
(30) El-Waer, A. F.; Douglas, K. T.; Smith, K.; Fairlamb, A. H.
Synthesis of N-Benzyloxycarbonyl-L-cysteinylglycine 3-Dimethy-
laminopropylamide Disulfide: A Cheap and Convenient New
Assay for Trypanothione Reductase. Anal. Biochem. 1991, 198,
212-216.
(31) Khan, M. O.; Austin, S. E.; Chan, C.; Yin, H.; Marks, D.;
Vaghjiani, S. N.; Kendrick, H.; Yardley, V.; Croft, S. L.; Douglas,
K. T. Use of an Additional Hydrophobic Binding Site, the Z Site,
in the Rational Drug Design of a New Class of Stronger
Trypanothione Reductase Inhibitor, Quaternary Alkylammo-
nium Phenothiazines. J. Med. Chem. 2000, 43, 3148-3156.
(32) Dixon, M.; Webb, E. C. Enzymes; Academic Press: New York,
1979; p 155.
(33) Atamna, H.; Krugliak, M.; Shalmiev, G.; Deharo, E.; Pescar-
mona, G.; Ginsburg, H. Mode of Antimalarial Effect of Methylene
Blue and Some of its Analogues on Plasmodium falciparum in
Culture and Their Inhibition of P. vinckei petteri and P. yoelii
nigeriensis in Vivo. Biochem. Pharmacol. 1996, 51, 693-700.
(34) Menezes, C. M. S.; Kirchgatter, K.; Di Santi, S. M.; Savalli, C.;
Monteiro, F. G.; Paula, G. A.; Ferreira, E. I. In Vitro Chloroquine
Resistance Modulation Study on Fresh Isolates of Brazilian
Plasmodium falciparum: Intrinsic Antimalarial Activity of
Phenothiazine Drugs. Mem. Inst. Oswaldo Cruz 2002, 97, 1033-
1039.
(40) Meinnel, T.; Mechulam, Y.; Fayat, G. Fast Purification of a
Functional Elongator tRNAmet Expressed from a Synthetic
Gene in Vivo. Nucleic Acids Res. 1988, 16(16), 8095-8096.
(41) Nordhoff, A.; Bu¨cheler, U. S.; Werner, D.; Schirmer, R. H.
Folding of the Four Domains and Dimerization Are Impaired
by the Gly446fGlu Exchange in Human Glutathione Reductase.
Implications for the Design of Antiparasitic Drugs. Biochemistry
1993, 32, 4060-4066.
(42) Worthington, D. J.; Rosemeyer, M. A. Human Glutathione
Reductase: Purification of the Crystalline Enzyme from Eryth-
rocytes. Eur. J. Biochem. 1974, 48, 167-177.
(43) Hirumi, H.; Hirumi, K. Continuous Cultivation of Trypanosoma
brucei Bloodstream Forms in a Medium Containing a Low
Concentration of Serum Protein Without Feeder Cell Layers. J.
Antimicrob. Chemother. 1989, 75, 985-989.
(44) Raz, B.; Iten, M.; Grether-Buhler, Y.; Kaminsky, R.; Brun, R.
The Alamar Blue Assay to Determine Drug Sensitivity of African
Trypanosomes (T. b. rhodesiense and T. b. gambiense) in Vitro.
Acta Trop. 1997, 68, 139-147.
(45) O’Neill, M. J.; Bray, D. H.; Boardman, P.; Phillipson, J. D.;
Warhurst, D. C. Plants as Sources of Antimalarial Drugs. Part.
1. In Vitro Test Method for the Evaluation of Crude Extracts
from Plants. Planta Med. 1985, 394-398.
(46) Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D.
Quantitative Assessment of Antimalarial Activity in Vitro by a
Semiautomated Microdilution Technique. Antimicrob. Agents
Chemother. 1979, 16, 710-718.
(47) Neal, R. A.; Croft, S. L. An in Vitro System for Determining the
Activity of Compounds Against the Intracellular Amastigote
Form of Leishmania donovani. J. Antimicrob. Chemother. 1984,
14, 463-475.
(48) Buckner, F. S.; Verlinde, C. L. M. J.; la Flamme, A. C.; van
Voorhis, W. C. Efficient Technique for Screening Drugs for
Activity Against Trypanosoma cruzi using Parasites Expressing
â-Galactosidase. Antimicrob. Agents Chemother. 1996, 40, 2592-
2597.
(49) Loudon, J. D. Mobility of Groups in 3-Chloro-4-nitro and
5-Chloro-2-nitrophenyl Sulfones. J. Chem. Soc. 1939, 902-904.
(50) Kuriyan, J.; Kong, X.-P.; Krishna, T. S. R.; Sweet, R. M.;
Murgolo, N. J.; Field, H.; Cerami, A.; Henderson, G. B. X-ray
Structure of Trypanothione Reductase from Crithidia fasciculata
at 2.4-Å Resolution. Proc. Natl. Acad. Sci. U.S.A. 1991, 88,
8764-8768.
(51) Bailey, S.; Smith, K.; Fairlamb, A. H.; Hunter, W. N. Substrate
Interactions Between Trypanothione Reductase and N1-Glu-
tathionylspermidine Disulphide at 0.28-nm Resolution. Eur. J.
Biochem. 1993, 213, 67-75.
(52) Zhang, Y.; Bond, C. S.; Bailey, S.; Cunningham, M. L.; Fairlamb,
A. H.; Hunter, W. N. The Crystal Structure of Trypanothione
Reductase from the Human Pathogen Trypanosoma cruzi at 2.3
Å Resolution. Protein Sci. 1996, 5, 52-61.
(35) Gracio, M. A.; Gracio, A. J.; Viveiros, M.; Amaral, L. Since
Phenothiazines Alter Antibiotic Susceptibility of Microorganisms
by Inhibiting Efflux Pumps, Are These Agents Useful for
Evaluating Similar Pumps in Phenothiazine-Sensitive Parasites?
Int. J. Antimicrob. Agents 2003, 22, 347-351.
(36) Guan, J.; Kyle, D. E.; Gerena, L.; Zhang, Q.; Milhous, W. K.;
Lin, A. J. Design, Synthesis, and Evaluation of New Chemosen-
sitizers in Multi-Drug-Resistant Plasmodium falciparum. J.
Med. Chem. 2002, 45, 2741-2748.
(37) Kalkanidis, M.; Klonis, N.; Tilley, L.; Deady, L. W. Novel
Phenothiazine Antimalarials: Synthesis, Antimalarial Activity,
and Inhibition of the Formation of â-Haematin. Biochem. Phar-
macol. 2002, 63, 833-842.
(38) Dominguez, J. N.; Lopez, S.; Charris, J.; Iarruso, L.; Lobo, G.;
Semenov, A.; Olson, J. E.; Rosenthal, P. J. Synthesis and
Antimalarial Effects of Phenothiazine Inhibitors of a Plasmo-
dium falciparum Cysteine Protease. J. Med. Chem. 1997, 40,
2726-2732.
(39) Kellam, B.; Bycroft, B. W.; Chhabra, S. R. Solid-Phase Applica-
tions of Dde and the Analogue Nde: Synthesis of Trypanothione
Disulfide. Tetrahedron Lett. 1997, 38, 4849-4852.
(53) SYBYL 6.4.2.; Tripos Inc., 1998.
(54) Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated Docking
of Flexible Ligands: Applications of AutoDock. J. Mol. Recognit.
1996, 9, 1-5.
(55) Goodford, P. J. A Computational Procedure for Determining
Energetically Favorable Binding Sites on Biologically Important
Macromolecules. J. Med. Chem. 1985, 28, 849-857.
(56) Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio,
C.; Alagona, G.; Weiner, P. K. A New Force Field for Molecular
Mechanical Simulation of Nucleic Acids and Proteins. J. Am.
Chem. Soc. 1984, 106, 765.
(57) Jacoby, E. M.; Schlichting, I.; Lantwin, C. B.; Kabsch, W.;
Krauth-Siegel, R. L. Crystal Structure of the Trypanosoma cruzi
Trypanothione Reductase‚Mepacrine Complex. Proteins 1996,
24, 73-80.
(58) Stewart, J. J. P. MOPAC: A Semiempirical Molecular Orbital
Program. J. Comput.-Aided Mol. Des. 1990, 4, 1-105.
JM050819T